Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2022 Jun 13;13:948031. doi: 10.3389/fimmu.2022.948031

Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response

Mark B Carascal 1,2,, Rance Derrick N Pavon 1,, Windell L Rivera 1,*
PMCID: PMC9235355  PMID: 35769471

In the original article, there was a mistake in Figure 4 as published. An old version of Figure 4 was used instead of the latest figure file. The corrected Figure 4 appears below.

Figure 4.

Figure 4

General construction process of recombinant protein, DNA, VLP, vector-based, and mRNA influenza vaccines.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES